Therapeutic Guidelines

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia

By

Important Information Guidelines updated: December 2025 Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections Opportunistic Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Provincial Best Practice in HIV Case Management Care of HIV […]

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Read More »

Care of HIV Positive Pregnant Women and Interventions to Reduce Perinatal Transmission Guidelines

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Supportive non-directive counseling regarding reproductive choices, high risk prenatal care, modified management of labour and delivery, and postpartum

Care of HIV Positive Pregnant Women and Interventions to Reduce Perinatal Transmission Guidelines Read More »

Provincial Best Practice in HIV Case Management

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections Opportunistic Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Provincial Best Practice in HIV Case Management Care of HIV Positive Pregnant Women and Interventions to

Provincial Best Practice in HIV Case Management Read More »

HIV Post-Exposure Prophylaxis (PEP) Guidelines

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia For information on how to obtain medication for prevention of HIV infection following a high risk occupational or

HIV Post-Exposure Prophylaxis (PEP) Guidelines Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search